Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1988-11-25
1990-06-19
Friedman, Stanley J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514812, A61K 3144
Patent
active
049354280
ABSTRACT:
A pharmaceutical composition in sublingual unit dosage form for maintenance treatment of opiate addicts comprising from 2 to 8 mg buprenorphine and an amount of naltrexone sufficient to substantially attenuate the euphorigenic effect of the buprenorphine when injected and to provide greater opiate blocking effect than that of naltrexone alone.
REFERENCES:
patent: 4661492 (1987-04-01), Lewis et al.
Friedman Stanley J.
Reckitt & Colman Products Limited
LandOfFree
Treating opiate dependence does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Treating opiate dependence, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treating opiate dependence will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2260540